Inari Medical, Inc.
NARI · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $4 | $3 | $5 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $4 | $3 | $4 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 28.7% | 38.4% | 98.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 88% | 88.4% | 91.1% | 90.6% |
| EBITDA | $0 | -$0 | $0 | $0 |
| % Margin | 3.1% | -4.8% | 5.6% | 11.7% |
| Net Income | -$0 | -$0 | $0 | $0 |
| % Margin | -0.3% | -7.6% | 3.6% | 9.9% |
| EPS Diluted | -0.029 | -0.55 | 0.18 | 0.27 |
| % Growth | 94.8% | -405.6% | -33.3% | – |
| Operating Cash Flow | $0 | -$0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | $0 | -$0 |